Holding(s) in Company

Summary by AI BETAClose X

Harwood Capital LLP has notified Renalytix PLC of a change in its major holding, with its total voting rights decreasing from 3.903% to 2.822%, representing 17,035,023 voting rights. This change occurred on September 8, 2026, and the notification was made on the same day. The decrease is attributed to changes in holdings within North Atlantic Smaller Companies Investment Trust Plc, Oryx International Growth Fund Limited, and Harwood Capital LLP itself, with the ultimate controlling person being Christopher Harwood Bernard Mills.

Disclaimer*

UK 100

Latest directors dealings